|
1
|
National Institute for Health and Care
Excellence (NICE). COVID-19 rapid guideline: Managing the long-term
effects ofCOVID-19. https://www.nice.org.uk/guidance/NG188. Accessed
February 1, 2023.
|
|
2
|
Soriano JB, Murthy S, Marshall JC, Relan P
and Diaz JV: WHO Clinical Case Definition Working Group On
Post-COVID-19 Condition. A clinical case definition of
post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis.
22:e102–e107. 2022.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Leta V, Rodríguez-Violante M, Abundes A,
Rukavina K, Teo JT, Falup-Pecurariu C, Irincu L, Rota S,
Bhidayasiri R, Storch A, et al: Parkinson's disease and
post-COVID-19 syndrome: The Parkinson's Long-COVID spectrum. Mov
Disord. 36:1287–1289. 2021.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Boika AV, Sialitski MM, Chyzhyk VA,
Ponomarev VV and Fomina EG: Post-COVID worsening of a Parkinson's
disease patient. Clin Case Rep. 9(e04409)2021.PubMed/NCBI View Article : Google Scholar
|
|
5
|
D'Iorio A, Baiano C, Maraucci G, Vitale C,
Amboni M and Santangelo G: A longitudinal study on the effects of
COVID-19 pandemic on non-motor symptoms in Parkinson's disease.
Neurol Sci. 43:4605–4609. 2022.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Khoshnood RJ, Zali A, Tafreshinejad A,
Ghajarzadeh M, Ebrahimi N, Safari S and Mirmosayyeb O: Parkinson's
disease and COVID-19: A systematic review and meta-analysis. Neurol
Sci. 43:775–783. 2022.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Antonini A, Leta V, Teo J and Chaudhuri
KR: Outcome of Parkinson's disease patients affected by COVID-19.
Mov Disord. 35:905–908. 2020.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Montanaro E, Artusi CA, Rosano C,
Boschetto C, Imbalzano G, Romagnolo A, Bozzali M, Rizzone MG,
Zibetti M and Lopiano L: Anxiety, depression, and worries in
advanced Parkinson disease during COVID-19 pandemic. Neurol Sci.
43:341–348. 2022.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Nalbandian A, Sehgal K, Gupta A, Madhavan
MV, McGroder C, Stevens JS, Cook JR, Nordvig AS, Shalev D, Sehrawat
TS, et al: Post-acute COVID-19 syndrome. Nat Med. 27:601–615.
2021.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Goerttler T, Kwon EH, Fleischer M,
Stettner M, Tönges L and Klebe S: SARS-CoV-2, COVID-19 and
Parkinson's disease-many issues need to be clarified-a critical
review. Brain Sci. 12(456)2022.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Yang L, Han Y, Nilsson-Payant BE, Gupta V,
Wang P, Duan X, Tang X, Zhu J, Zhao Z, Jaffré F, et al: A human
pluripotent stem cell-based platform to study SARS-CoV-2 tropism
and model virus infection in human cells and organoids. Cell Stem
Cell. 27:125–136.e7. 2020.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Emmi A, Rizzo S, Barzon L, Sandre M,
Carturan E, Sinigaglia A, Riccetti S, Barbera MD, Boscolo-Berto R,
Cocco P, et al: Detection of SARS-CoV-2 viral proteins and genomic
sequences in human brainstem nuclei. NPJ Parkinsons Dis.
9(25)2023.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Mysiris DS, Vavougios GD, Karamichali E,
Papoutsopoulou S, Stavrou VT, Papayianni E, Boutlas S, Mavridis T,
Foka P, Zarogiannis SG, et al: Post-COVID-19 parkinsonism and
parkinson's disease pathogenesis: The exosomal cargo hypothesis.
Int J Mol Sci. 23(9739)2022.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Angelopoulou E, Karlafti E, Georgakopoulou
VE, Papalexis P, Papageorgiou SG, Tegos T and Savopoulos C:
Exploring the role of ACE2 as a connecting link between COVID-19
and Parkinson's disease. Life (Basel). 13(536)2023.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Braak H, Rüb U, Gai WP and Tredici KD:
Idiopathic Parkinson's disease: Possible routes by which vulnerable
neuronal types may be subject to neuroinvasion by an unknown
pathogen. J Neural Transm (Vienna). 110:517–536. 2003.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Pfeiffer RF: Non-motor symptoms in
Parkinson's disease. Parkinsonism Relat Disord. 22 (Suppl
1):S119–S122. 2016.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Miller IN and Cronin-Golomb A: Gender
differences in Parkinson's disease: Clinical characteristics and
cognition. Mov Disord. 25:2695–2703. 2010.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Angelopoulou E, Papadopoulos AN,
Spantideas N and Bougea A: Migraine, tension-type headache and
Parkinson's disease: A systematic review and meta-analysis.
Medicina (Kaunas). 58(1684)2022.PubMed/NCBI View Article : Google Scholar
|
